- Home
- CLBT vs ADMA Comparison
CLBT vs ADMA Comparison
Compare CLBT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBT
- ADMA
- Stock Information
- Founded
- CLBT 1999
- ADMA 2004
- Country
- CLBT Israel
- ADMA United States
- Employees
- CLBT N/A
- ADMA N/A
- Industry
- CLBT Computer Software: Prepackaged Software
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLBT Technology
- ADMA Health Care
- Exchange
- CLBT Nasdaq
- ADMA Nasdaq
- Market Cap
- CLBT 4.6B
- ADMA 4.1B
- IPO Year
- CLBT N/A
- ADMA N/A
- Fundamental
- Price
- CLBT $18.90
- ADMA $21.31
- Analyst Decision
- CLBT Strong Buy
- ADMA Strong Buy
- Analyst Count
- CLBT 7
- ADMA 4
- Target Price
- CLBT $23.43
- ADMA $22.50
- AVG Volume (30 Days)
- CLBT 1.1M
- ADMA 3.7M
- Earning Date
- CLBT 05-14-2025
- ADMA 05-08-2025
- Dividend Yield
- CLBT N/A
- ADMA N/A
- EPS Growth
- CLBT N/A
- ADMA N/A
- EPS
- CLBT N/A
- ADMA 0.81
- Revenue
- CLBT $401,203,000.00
- ADMA $426,454,000.00
- Revenue This Year
- CLBT $23.09
- ADMA $18.45
- Revenue Next Year
- CLBT $17.61
- ADMA $26.96
- P/E Ratio
- CLBT N/A
- ADMA $26.31
- Revenue Growth
- CLBT 23.41
- ADMA 65.16
- 52 Week Low
- CLBT $10.25
- ADMA $6.01
- 52 Week High
- CLBT $26.30
- ADMA $23.64
- Technical
- Relative Strength Index (RSI)
- CLBT 48.47
- ADMA 60.16
- Support Level
- CLBT $17.45
- ADMA $17.30
- Resistance Level
- CLBT $19.80
- ADMA $22.25
- Average True Range (ATR)
- CLBT 1.01
- ADMA 1.50
- MACD
- CLBT 0.07
- ADMA 0.16
- Stochastic Oscillator
- CLBT 67.39
- ADMA 83.62
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.